Medically reviewed by Nicholas R. Metrus, MD Huntington’s disease is a hereditary disorder that causes a progressive decline ...

Vesicular monoamine transporter 2 (VMAT2) inhibitors are a type of medication used to manage a specific type of motor symptom in Huntington’s disease known as chorea. Chorea refers to the ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

The FDA has approved Austedo (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease (HD). Formerly known as SD-809, Austedo is the first drug containing ...

The fellows gain expertise in diagnosing and treating Parkinson’s disease, atypical Parkinsonian syndromes, dystonia, tremor, Huntington’s disease, chorea, myoclonus, ballism, Tourette syndrome, tics, ...

Huntington's disease (HD) is a hereditary neurodegenerative ... The movement disorder is characterized by involuntary movements known as chorea, and by the impairment of voluntary movements. The ...

Drug Significantly Reduces Chorea Symptoms in Patients With Huntington's Disease May 19, 2023 — The drug valbenazine statistically improves chorea, a movement disorder commonly associated with ...